HOME >> MEDICINE >> NEWS
Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference

Napa, CA (May 21, 2007) -- Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD). "Nebulized Formoterol is an Effective Bronchodilator and Improves the Quality of Life for COPD Patients" presented results of the Phase III pivotal clinical study, a 12-week randomized, double-blind, double-dummy, placebo- and active-controlled trial. The trial found that Perforomist Inhalation Solution, a twice-daily, long-acting beta2-agonist (LABA):

  • provided rapid bronchodilation that lasted a full 12 hours,
  • enabled patients to use less rescue medication,
  • maintained improvements in lung function with no evidence of tolerance (tachyphylaxis) over the 12-week period, and
  • improved the lung function and quality of life of patients compared to placebo.

No significant difference in efficacy was observed over 12 weeks of treatment between Perforomist Inhalation Solution and the active comparator, dry powder Foradil.

A separate presentation given at ATS detailed the safety results of the same trial. "Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD Patients" found that Perforomist Inhalation Solution was well tolerated, had a safety profile similar to that of Foradil, and resulted in fewer COPD exacerbations than was seen with placebo. Taken together, the data from these two presentations demonstrate that Perforomist Inhalation Solution will provide a new, safe and effective therapeutic option for long-term maintenance treatment of COPD.

Nicholas J. Gross, MD, PhD, an expert on lung diseases, particularly COPD, was the Principal Investigator for the Phase III pivo
'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-577-8110
Feinstein Kean Healthcare
21-May-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical guidelines for blood conservation during cardiac procedures developed
6. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2019)... (PRWEB) , ... October 11, 2019 , ... A Topping ... (STA) new headquarters facility by general contractors Adolfson & Peterson Construction. The event celebrated ... 2020 at 8190 Midtown Road in Dallas. The first of its kind in Texas, ...
(Date:10/8/2019)... ... 08, 2019 , ... Safe Harvest soups in glass jars ... Fry’s, Roundy’s, Smiths and Dillons. , Safe Harvest reinvented classic soup recipes to ... and fresh taste is paramount for us,” says Bryan Boches, co-founder of Safe ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... services for the Department of Veterans Affairs Community Care Referrals and Authorizations program. ... of the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... pathologists, 4medica® President Gregg Church will inform conference attendees how the ... labs orders management-by starting with the right, clean patient data. The single platform ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... biomimetic dentistry techniques, has recently attended an advanced Level III training in Cagliari, ... of dentistry. The training took place September 16-19, 2019 at the Sardinia Dental ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... ... fitness studios have teamed up to create the first ever Hell’s Kitchen Sweat Crawl, a ... the top group exercise classes offered on the West Side of Manhattan. Held on Saturday, ... the Hell’s Kitchen Sweat Crawl will feature 25-minute workout classes at Club Pilates , ...
(Date:10/11/2019)... ... 11, 2019 , ... MindShare Technology Founder and CEO Greg Povolny will offer ... Strong Families and Communities National Conference. The conference is at the Westin Indianapolis hotel ... 5:00 p.m. , Povolny’s presentation will provide real world examples of how to ...
(Date:10/10/2019)... ... ... Smile Brands Inc. together with its affiliate A+ Dental Care announced today the ... location in Natomas. , A+ Dental Care (“A+”) is a rapidly growing group dental ... and three specialists work together as a team to provide comprehensive, personalized dental care ...
Breaking Medicine Technology:
Cached News: